https://eirventures.eu/eir-ventures-invests-in-purpose-pharma/2025-02-20T10:17:38+00:00https://eirventures.eu/hoba-therapeutics-raises-eur-23-million/2025-02-20T10:17:52+00:00https://eirventures.eu/eir-ventures-invests-in-dania-tx/2025-02-20T10:47:08+00:00https://eirventures.eu/eir-ventures-celebrates-3-years-anniversary/2025-02-20T10:47:19+00:00https://eirventures.eu/lovisa-bacekmar-new-principal/2025-05-22T09:06:44+00:00https://eirventures.eu/eir-invests-in-rapp/2025-02-20T10:17:22+00:00https://eirventures.eu/eir-invests-in-gutcrine/2025-02-20T10:19:07+00:00https://eirventures.eu/eir-ventures-invests-in-henlez/2025-02-20T10:21:59+00:00https://eirventures.eu/eir-ventures-portfolio-company-pretzel-therapeutics-announces-usd-725m-series-a-financing/2025-02-20T10:25:10+00:00https://eirventures.eu/eir-ventures-invests-in-hoba-therapeutics/2025-02-20T10:26:53+00:00https://eirventures.eu/eir-ventures-joins-oversubscribed-investment-round-in-attgeno/2025-02-20T10:37:59+00:00https://eirventures.eu/eir-ventures-strengthens-team-appoints-three-new-partners/2025-02-20T10:41:41+00:00https://eirventures.eu/eir-ventures-joins-oversubscribed-investment-round-in-cinclus-pharma/2025-02-20T10:43:47+00:00https://eirventures.eu/eir-ventures-leads-e28m-investment-in-scenic-biotec/2025-02-20T10:45:55+00:00https://eirventures.eu/eir-ventures-today-announced-the-completion-of-an-investment-in-strike-pharma/2025-02-20T10:48:48+00:00https://eirventures.eu/eir-ventures-announces-co-investment-agreement-with-copenhagen-university/2025-02-20T11:17:41+00:00https://eirventures.eu/eir-ventures-is-happy-to-welcome-two-interns/2025-02-20T11:19:38+00:00https://eirventures.eu/eir-ventures-expands-team-with-new-principal/2025-02-20T11:22:09+00:00https://eirventures.eu/eir-ventures-closes-life-science-venture-fund-at-eur122-million/2025-02-20T11:26:34+00:00https://eirventures.eu/eir-ventures-completes-investment-in-arguseye/2025-02-20T11:29:07+00:00https://eirventures.eu/eir-ventures-upscales-with-investment-associate/2025-02-20T11:31:25+00:00https://eirventures.eu/eir-ventures-first-seedling-synklino-aps-completes-oversubscribed-dkk-106-million-series-a-round/2025-02-20T11:34:11+00:00https://eirventures.eu/io-biotech-inc-announces-pricing-of-initial-public-offering/2025-02-20T11:36:59+00:00https://eirventures.eu/galecto-announces-clinical-collaboration-with-roche/2025-02-20T11:47:02+00:00https://eirventures.eu/eir-ventures-completes-investment-in-one-carbon-therapeutics/2025-02-20T11:48:40+00:00https://eirventures.eu/purpose-pharma-announces-positive-chmp-opinion-for-attrogy/2025-04-29T06:12:47+00:00https://eirventures.eu/cinclus-pharma-partners-with-zentiva-in-e220m-deal-to-commercialize-linaprazan-glurate-in-europe/2025-05-22T09:13:56+00:00https://eirventures.eu/three-eir-ventures-companies-featured-in-nature/2025-08-18T12:25:23+00:00